Nothing Special   »   [go: up one dir, main page]

ITMI20021080A1 - Associazioni farmaceutiche per uso topico a base di chelati del ferroinibitori delle metalloproteasi e fattore xiii per il trattamento dell - Google Patents

Associazioni farmaceutiche per uso topico a base di chelati del ferroinibitori delle metalloproteasi e fattore xiii per il trattamento dell

Info

Publication number
ITMI20021080A1
ITMI20021080A1 IT2002MI001080A ITMI20021080A ITMI20021080A1 IT MI20021080 A1 ITMI20021080 A1 IT MI20021080A1 IT 2002MI001080 A IT2002MI001080 A IT 2002MI001080A IT MI20021080 A ITMI20021080 A IT MI20021080A IT MI20021080 A1 ITMI20021080 A1 IT MI20021080A1
Authority
IT
Italy
Prior art keywords
proteasis
ferroinhibitors
chelates
treatment
metal
Prior art date
Application number
IT2002MI001080A
Other languages
English (en)
Inventor
Marcello Izzo
Paolo Zamboni
Original Assignee
Marcello Izzo
Paolo Zamboni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marcello Izzo, Paolo Zamboni filed Critical Marcello Izzo
Priority to IT2002MI001080A priority Critical patent/ITMI20021080A1/it
Publication of ITMI20021080A0 publication Critical patent/ITMI20021080A0/it
Priority to EP03011214A priority patent/EP1364645A1/en
Publication of ITMI20021080A1 publication Critical patent/ITMI20021080A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/02—Aminoacyltransferases (2.3.2)
    • C12Y203/02013—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT2002MI001080A 2002-05-21 2002-05-21 Associazioni farmaceutiche per uso topico a base di chelati del ferroinibitori delle metalloproteasi e fattore xiii per il trattamento dell ITMI20021080A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT2002MI001080A ITMI20021080A1 (it) 2002-05-21 2002-05-21 Associazioni farmaceutiche per uso topico a base di chelati del ferroinibitori delle metalloproteasi e fattore xiii per il trattamento dell
EP03011214A EP1364645A1 (en) 2002-05-21 2003-05-16 Pharmaceutical combinations for topical use based on iron chelators, metalloprotease inhibitors and factor XIII for the treatment of lipodermatosclerosis and trophic lesions of the cutaneous tissues and muccous membranes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001080A ITMI20021080A1 (it) 2002-05-21 2002-05-21 Associazioni farmaceutiche per uso topico a base di chelati del ferroinibitori delle metalloproteasi e fattore xiii per il trattamento dell

Publications (2)

Publication Number Publication Date
ITMI20021080A0 ITMI20021080A0 (it) 2002-05-21
ITMI20021080A1 true ITMI20021080A1 (it) 2003-11-21

Family

ID=11449936

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI001080A ITMI20021080A1 (it) 2002-05-21 2002-05-21 Associazioni farmaceutiche per uso topico a base di chelati del ferroinibitori delle metalloproteasi e fattore xiii per il trattamento dell

Country Status (2)

Country Link
EP (1) EP1364645A1 (it)
IT (1) ITMI20021080A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007119444A (ja) * 2005-09-29 2007-05-17 Shiseido Co Ltd Ａｄａｍ阻害剤によるしわの防止または改善
US10266560B2 (en) 2014-11-06 2019-04-23 Enanta Pharmaceuticals, Inc. Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
US11578097B2 (en) 2014-11-26 2023-02-14 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
RU2017121457A (ru) * 2014-11-26 2018-12-26 Энанта Фармасьютикалс, Инк. Аналоги желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения
MX2017010376A (es) 2015-02-11 2017-12-20 Enanta Pharm Inc Análogos de ácido biliar como agonistas de fxr/tgr5 y métodos para el uso de los mismos.
RS62110B1 (sr) 2015-03-31 2021-08-31 Enanta Pharm Inc Derivati žučnih kiselina kao agonisti fxr/tgr5 i postupci njihove upotrebe
WO2017147174A1 (en) 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
US10364267B2 (en) 2016-02-23 2019-07-30 Enanta Pharmaceuticals, Inc. Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
US10323060B2 (en) 2016-02-23 2019-06-18 Enanta Pharmaceuticals, Inc. Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
US10584145B2 (en) 2016-11-29 2020-03-10 Enanta Pharmaceuticals, Inc. Process for preparation of sulfonylurea bile acid derivatives
US10472386B2 (en) 2017-02-14 2019-11-12 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR agonists and methods of use thereof
AU2018223231B2 (en) * 2017-02-27 2023-09-28 Zeroscar Pty Ltd Methods and products for reducing adhesions
WO2018187804A1 (en) 2017-04-07 2018-10-11 Enanta Pharmaceuticals, Inc. Process for preparation of sulfonyl carbamate bile acid derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2376886A (en) * 2001-06-27 2002-12-31 Johnson & Johnson Medical Ltd Treatment and prevention of lipodermatosclerosis

Also Published As

Publication number Publication date
ITMI20021080A0 (it) 2002-05-21
EP1364645A1 (en) 2003-11-26

Similar Documents

Publication Publication Date Title
ITMI20021080A1 (it) Associazioni farmaceutiche per uso topico a base di chelati del ferroinibitori delle metalloproteasi e fattore xiii per il trattamento dell
ITMI20020756A0 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
NO20043904L (no) Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
DE60329318D1 (de) 4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
ATE411315T1 (de) Stickstoff enthaltende kondensierte ringverbindung und deren verwendung als hiv- integrasehemmer
DE60201988D1 (de) Pharmazeutische dosierungsform von amorphem nilfenavir mesylat
NO20033384D0 (no) Farmasöytisk formulering
NO20031653D0 (no) Metallkatalysator samt fremstilling og anvendelse derav
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
NO20033785D0 (no) Farmasöytisk formulering
NO20035627D0 (no) Farmasöytisk formulering
NO20052278L (no) Piperazinyl- og diazapanyl-benzamider og -benztioamider
DK1411921T4 (da) Farmaceutiske sammensætninger indeholdende terbinafin og anvendelse deraf
ITMI20021247A1 (it) Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
AU2002357063A8 (en) Novel topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
NO20043576L (no) Pharmaceutical formulation comprising melatonin
DK1849468T3 (da) Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
ITMI20020986A1 (it) Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo
DE60238856D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
ITRM20040223A1 (it) Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
FR2806301B1 (fr) Composition a base de sphingolipide et de beta-hydroxy-acide utilisable par voie topique pour les soins de la peau
NO20034785D0 (no) Farmasöytiske kombinasjoner basert på pyridoindolon-derivater og anticancermidler
ITRM20020612A1 (it) Composto terapeutico per la cura topica delle vulvovaginiti e delle micosi in genere.